Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Subscription Receivable - Related Parties	Accumulated Deficit
Balance at Dec. 31, 2019	$ 6,835,418		$ 164	$ 35,857,835	$ (7,447)	$ (29,015,134)
Balance, shares at Dec. 31, 2019			16,393,171
Stock option compensation	252,072			252,072
Restricted stock unit compensation	163,100			163,100
Stock options exercised	28,575			28,575
Stock options exercised, shares			40,869
Stock options exercised - cashless
Stock options exercised - cashless, shares			2,645
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares			36,650
Net loss	(4,058,216)					(4,058,216)
Balance at Mar. 31, 2020	3,220,949		$ 164	36,301,582	(7,447)	(33,073,350)
Balance, shares at Mar. 31, 2020			16,473,335
Balance at Dec. 31, 2020	(4,510,413)		$ 177	39,725,445		(44,236,035)
Balance, shares at Dec. 31, 2020			17,741,713
Stock option compensation	6,647			6,647
Restricted stock unit compensation	3,761,027			3,761,027
Warrants exercised	64,540		$ 1	64,539
Warrants exercised, shares			20,232
Warrants exercised – cashless
Warrants exercised – cashless, shares			61,484
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares
Common stock issued for cash, shares			2,530,000
Common stock issued for cash	29,727,500		$ 25	29,727,475
Offering costs	(2,126,305)			(2,126,305)
Net loss	(7,206,535)					(7,206,535)
Balance at Mar. 31, 2021	$ 19,716,461		$ 203	$ 71,158,828		$ (51,442,570)
Balance, shares at Mar. 31, 2021			20,353,429